Cellectis CLLS
NASDAQ CLLS
$1.38 +0.27 (+24.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Cellectis (CLLS) Current Deferred Tax Liability (2024)

Updated

Analysis

Cellectis (CLLS) Current Deferred Tax Liability (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cellectis 111.38 Mn -642.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 122,000.00
Mar 31, 2024 137,000.00
API Access

Cellectis Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=CLLS&period=max&api_key=YOUR_API_KEY